Type 2 myocardial infarction

Heart

Volumn 101, Issue 2, 2015, Pages 89-90

  Collinson, P O ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN; ANTITHROMBOCYTIC AGENT;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR MORTALITY; DISEASE CLASSIFICATION; EDITORIAL; HEART INFARCTION; HUMAN; MEDICAL HISTORY; MYOCARDIAL INFARCTION TYPE 2; PATIENT IDENTIFICATION; PROCESS OPTIMIZATION; PROGNOSIS; PROTEIN DETERMINATION; ANEMIA; FEMALE; HEART MUSCLE REVASCULARIZATION; MALE; RENAL INSUFFICIENCY;

ANEMIA; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PLATELET AGGREGATION INHIBITORS; RENAL INSUFFICIENCY;

EID: 84920544562     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-306865     Document Type: Editorial

References (6)

1. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13.
2. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67.
3. Baron T, Hambraeus K, Sundstrom J, et al. Type 2 myocardial infarction in clinical practice. Heart 2015;101:101-6.
4. Saaby L, Poulsen TS, Diederichsen AC, et al. Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort. Am J Med 2014;127:295-302.
5. Mills NL, Churchhouse AM, Lee KK, et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011;305:1210-16.
6. Blich M, Sebbag A, Attias J, et al. Cardiac troponin I elevation in hospitalized patients without acute coronary syndromes. Am J Cardiol 2008;101:1384-8.